I N D U S T R Y I N V E S T I G A T I O N
THE EXPANDING CYBERSECURITY THREAT TO PHARMACEUTICAL COMPANIES
In an increasingly digitised world , the cybersecurity threat to pharmaceutical companies has reached unparalleled levels . Mark Clark , VP Sales EMEA North at Onapsis , emphasises the urgent need for robust cybersecurity measures as healthcare organisations become prime targets for cyberattacks and pharmaceutical companies face escalating risks .
Not that long ago , most pharmaceutical companies were probably more concerned about the physical security of their labs and offices over digital security . After all , if a competitor or state-backed actor was looking to get inside information or commit an act of sabotage , that ’ s the route they ’ d most likely take . But as the industry , like so many others , has become increasingly digitised , so has the threat of cybercrime .
In fact , cyberattacks targeting healthcare organisations increased 74 % from 2021 to 2022 . It ’ s hardly coincidental that such
www . intelligenthealth . tech 39